USE OF THREONINE FOR THE TREATMENT OF PHENYLKETONURIA

摘要

The invention relates to the use of threonine for the treatment of phenylketonuria (PKU). The invention is based on the surprising discovery that the concentration of phenylalanine in the plasma of PKU patients can be reduced by additional doses of threonine. The object of the invention is therefore an agent for dietetic or pharmaceutical use in case of phenylketonuria, which agent contains at least 8 g threonine per 100 g amino acids. This agent may be foods, in particular formula foods and PKU dietary foods.